Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
To determine the safety and tolerance of subcutaneous injections of natural interferon alpha (IFN) in asymptomatic HIV-positive persons and record its effects on the HIV virus in these individuals.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria
Patients must have:
Prior Medication:
Allowed:
Exclusion Criteria
Co-existing Condition:
Patients with the following symptoms or conditions are excluded:
Concurrent Medication:
Excluded:
Patients with the following prior conditions are excluded:
Prior Medication:
Excluded within 5 days prior to study entry:
Excluded within 45 days prior to study entry:
Excluded within 3 months prior to study entry:
Any form of interferon.
Antiviral therapy.
Immunoregulatory therapy (other than acyclovir).
Unlikely or unable to comply with the requirements of the protocol.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal